Rank | Gene Set | Z-score |
---|---|---|
1 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.31709598 |
2 | nucleobase catabolic process (GO:0046113) | 5.42751037 |
3 | vocalization behavior (GO:0071625) | 4.83666694 |
4 | neuron cell-cell adhesion (GO:0007158) | 4.79818618 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.32008966 |
6 | L-phenylalanine catabolic process (GO:0006559) | 4.32008966 |
7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.24355546 |
8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.23906178 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.15744749 |
10 | L-phenylalanine metabolic process (GO:0006558) | 4.15744749 |
11 | protein localization to synapse (GO:0035418) | 4.08252635 |
12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.08010503 |
13 | synaptic vesicle maturation (GO:0016188) | 3.90534039 |
14 | proline transport (GO:0015824) | 3.89789515 |
15 | coenzyme catabolic process (GO:0009109) | 3.85605941 |
16 | cellular ketone body metabolic process (GO:0046950) | 3.83587696 |
17 | presynaptic membrane assembly (GO:0097105) | 3.81041018 |
18 | auditory behavior (GO:0031223) | 3.79330787 |
19 | cell migration in hindbrain (GO:0021535) | 3.70914085 |
20 | aromatic amino acid family catabolic process (GO:0009074) | 3.67902440 |
21 | layer formation in cerebral cortex (GO:0021819) | 3.66879215 |
22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.64323069 |
23 | presynaptic membrane organization (GO:0097090) | 3.62369692 |
24 | neurofilament cytoskeleton organization (GO:0060052) | 3.61439017 |
25 | synaptic vesicle exocytosis (GO:0016079) | 3.56979361 |
26 | neurotransmitter secretion (GO:0007269) | 3.55125536 |
27 | gamma-aminobutyric acid transport (GO:0015812) | 3.52278895 |
28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.51233537 |
29 | dendritic spine morphogenesis (GO:0060997) | 3.50978276 |
30 | glutamate secretion (GO:0014047) | 3.48536524 |
31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.42723809 |
32 | neuron recognition (GO:0008038) | 3.36810426 |
33 | negative regulation of microtubule polymerization (GO:0031115) | 3.36225717 |
34 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.34686163 |
35 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.31933050 |
36 | ketone body metabolic process (GO:1902224) | 3.29183644 |
37 | exploration behavior (GO:0035640) | 3.28620644 |
38 | alkaloid metabolic process (GO:0009820) | 3.27273880 |
39 | locomotory exploration behavior (GO:0035641) | 3.22934554 |
40 | neuronal ion channel clustering (GO:0045161) | 3.20025723 |
41 | regulation of synapse structural plasticity (GO:0051823) | 3.17152892 |
42 | bile acid and bile salt transport (GO:0015721) | 3.14681765 |
43 | kynurenine metabolic process (GO:0070189) | 3.14606248 |
44 | mechanosensory behavior (GO:0007638) | 3.12562326 |
45 | axon extension (GO:0048675) | 3.12224955 |
46 | behavioral response to cocaine (GO:0048148) | 3.09835955 |
47 | indole-containing compound catabolic process (GO:0042436) | 3.09475226 |
48 | indolalkylamine catabolic process (GO:0046218) | 3.09475226 |
49 | tryptophan catabolic process (GO:0006569) | 3.09475226 |
50 | neurotransmitter catabolic process (GO:0042135) | 3.09252713 |
51 | sulfur amino acid catabolic process (GO:0000098) | 3.08733650 |
52 | high-density lipoprotein particle remodeling (GO:0034375) | 3.07448926 |
53 | neurotransmitter transport (GO:0006836) | 3.06294595 |
54 | regulation of neurotransmitter levels (GO:0001505) | 3.05173148 |
55 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.02477613 |
56 | positive regulation of synapse maturation (GO:0090129) | 3.02201703 |
57 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.02194494 |
58 | postsynaptic membrane organization (GO:0001941) | 2.99964384 |
59 | aromatic amino acid family metabolic process (GO:0009072) | 2.99523863 |
60 | retinal ganglion cell axon guidance (GO:0031290) | 2.98866449 |
61 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.97769637 |
62 | bile acid biosynthetic process (GO:0006699) | 2.96782721 |
63 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.95685515 |
64 | synaptic transmission, glutamatergic (GO:0035249) | 2.95441853 |
65 | response to histamine (GO:0034776) | 2.94852013 |
66 | phenol-containing compound catabolic process (GO:0019336) | 2.94194877 |
67 | urea cycle (GO:0000050) | 2.93402576 |
68 | urea metabolic process (GO:0019627) | 2.93402576 |
69 | cellular modified amino acid catabolic process (GO:0042219) | 2.92471394 |
70 | tyrosine metabolic process (GO:0006570) | 2.89821870 |
71 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.89532235 |
72 | mitochondrion transport along microtubule (GO:0047497) | 2.89532235 |
73 | positive regulation of amino acid transport (GO:0051957) | 2.87679505 |
74 | activation of protein kinase A activity (GO:0034199) | 2.86905508 |
75 | spinal cord development (GO:0021510) | 2.86473341 |
76 | response to auditory stimulus (GO:0010996) | 2.85945269 |
77 | glyoxylate metabolic process (GO:0046487) | 2.83658909 |
78 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.82940543 |
79 | behavioral response to nicotine (GO:0035095) | 2.82703009 |
80 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.82595104 |
81 | prepulse inhibition (GO:0060134) | 2.81216219 |
82 | social behavior (GO:0035176) | 2.80621004 |
83 | intraspecies interaction between organisms (GO:0051703) | 2.80621004 |
84 | tryptophan metabolic process (GO:0006568) | 2.78125792 |
85 | regulation of respiratory system process (GO:0044065) | 2.77630311 |
86 | serine family amino acid catabolic process (GO:0009071) | 2.77246549 |
87 | flavonoid metabolic process (GO:0009812) | 2.77079957 |
88 | hippocampus development (GO:0021766) | 2.76365068 |
89 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.76218168 |
90 | cell-cell junction maintenance (GO:0045217) | 2.75458983 |
91 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.74825617 |
92 | synaptic transmission, cholinergic (GO:0007271) | 2.74401562 |
93 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.74362262 |
94 | regulation of vesicle fusion (GO:0031338) | 2.73984909 |
95 | glutamate metabolic process (GO:0006536) | 2.73673730 |
96 | drug catabolic process (GO:0042737) | 2.73391956 |
97 | dopamine biosynthetic process (GO:0042416) | 2.73383759 |
98 | synapse assembly (GO:0007416) | 2.73360848 |
99 | alpha-linolenic acid metabolic process (GO:0036109) | 2.72924922 |
100 | nitrogen cycle metabolic process (GO:0071941) | 2.72314339 |
101 | negative regulation of fibrinolysis (GO:0051918) | 2.71913837 |
102 | indolalkylamine metabolic process (GO:0006586) | 2.71790318 |
103 | regulation of axon guidance (GO:1902667) | 2.71582347 |
104 | neuronal action potential propagation (GO:0019227) | 2.71366039 |
105 | cysteine metabolic process (GO:0006534) | 2.70904284 |
106 | axonal fasciculation (GO:0007413) | 2.70701610 |
107 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.70418149 |
108 | bile acid metabolic process (GO:0008206) | 2.69784525 |
109 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.69578127 |
110 | dendrite morphogenesis (GO:0048813) | 2.69178735 |
111 | establishment of mitochondrion localization (GO:0051654) | 2.68273657 |
112 | regulation of cholesterol esterification (GO:0010872) | 2.67538965 |
113 | negative regulation of axon extension (GO:0030517) | 2.67084942 |
114 | regulation of fibrinolysis (GO:0051917) | 2.66603932 |
115 | regulation of synaptic vesicle transport (GO:1902803) | 2.65437863 |
116 | synapse organization (GO:0050808) | 2.65251144 |
117 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.64937743 |
118 | adult walking behavior (GO:0007628) | 2.64731333 |
119 | alanine transport (GO:0032328) | 2.64571588 |
120 | membrane depolarization during action potential (GO:0086010) | 2.64442380 |
121 | transmission of nerve impulse (GO:0019226) | 2.64433620 |
122 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.64001238 |
123 | cerebellum development (GO:0021549) | 2.62723046 |
124 | sympathetic nervous system development (GO:0048485) | 2.62417596 |
125 | negative regulation of cholesterol transport (GO:0032375) | 2.62164762 |
126 | negative regulation of sterol transport (GO:0032372) | 2.62164762 |
127 | negative regulation of axonogenesis (GO:0050771) | 2.61981837 |
128 | neuron-neuron synaptic transmission (GO:0007270) | 2.61940822 |
129 | nonmotile primary cilium assembly (GO:0035058) | 2.61857443 |
130 | dopamine transport (GO:0015872) | 2.61603820 |
131 | catecholamine transport (GO:0051937) | 2.61596480 |
132 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.61428153 |
133 | neuromuscular process controlling posture (GO:0050884) | 2.61377709 |
134 | positive regulation of synapse assembly (GO:0051965) | 2.60124235 |
135 | glutamate receptor signaling pathway (GO:0007215) | 2.60099524 |
136 | mating behavior (GO:0007617) | 2.59953730 |
137 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.59948440 |
138 | membrane hyperpolarization (GO:0060081) | 2.55894630 |
139 | response to dietary excess (GO:0002021) | 2.54112022 |
140 | neuron projection extension (GO:1990138) | 2.51968040 |
141 | central nervous system neuron axonogenesis (GO:0021955) | 2.50655849 |
142 | neuromuscular synaptic transmission (GO:0007274) | 2.50207324 |
143 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.49925851 |
144 | cell junction maintenance (GO:0034331) | 2.48644368 |
145 | startle response (GO:0001964) | 2.46878547 |
146 | dopamine receptor signaling pathway (GO:0007212) | 2.46719909 |
147 | organelle transport along microtubule (GO:0072384) | 2.46321988 |
148 | regulation of feeding behavior (GO:0060259) | 2.46309272 |
149 | short-term memory (GO:0007614) | 2.44800647 |
150 | glycosphingolipid biosynthetic process (GO:0006688) | 2.43519343 |
151 | regulation of respiratory gaseous exchange (GO:0043576) | 2.41764667 |
152 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.41349732 |
153 | negative regulation of axon guidance (GO:1902668) | 2.40782963 |
154 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.40780063 |
155 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.40780063 |
156 | neuron migration (GO:0001764) | 2.40189290 |
157 | head development (GO:0060322) | 2.38713408 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.82259680 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.33086281 |
3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.26902906 |
4 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.94566100 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.77766705 |
6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77065460 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.67557964 |
8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.63668774 |
9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.53585886 |
10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46651821 |
11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.43162278 |
12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42114574 |
13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42114574 |
14 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.37745273 |
15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.36110148 |
16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35361261 |
17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.34974956 |
18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30010642 |
19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.26992895 |
20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26364859 |
21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22047828 |
22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.18665408 |
23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17765733 |
24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17727539 |
25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16761071 |
26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.10790308 |
27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06645479 |
28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90308928 |
29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85860870 |
30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85560143 |
31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.84625278 |
32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82083753 |
33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82011221 |
34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.76323495 |
35 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.74552286 |
36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.72083567 |
37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69882587 |
38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65819204 |
39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60631453 |
40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60035774 |
41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56960393 |
42 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.56417943 |
43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50344493 |
44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.49977090 |
45 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.46797487 |
46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.45178908 |
47 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41863863 |
48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38079970 |
49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37684456 |
50 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.37173878 |
51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36274364 |
52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28998954 |
53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27026680 |
54 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.24427912 |
55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24282418 |
56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18962711 |
57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18564470 |
58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17846004 |
59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17433650 |
60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16775163 |
61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14236044 |
62 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.11582946 |
63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10854269 |
64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10057483 |
65 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.07223222 |
66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06838178 |
67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06483571 |
68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06038174 |
69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05289002 |
70 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.04587485 |
71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03090216 |
72 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02944397 |
73 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02880072 |
74 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97822345 |
75 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97184813 |
76 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96375158 |
77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94669846 |
78 | AR_19668381_ChIP-Seq_PC3_Human | 0.91928926 |
79 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.91440509 |
80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91311629 |
81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90686999 |
82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90686999 |
83 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.90483756 |
84 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90462044 |
85 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88048651 |
86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87983969 |
87 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.87364353 |
88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.86477726 |
89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86474669 |
90 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86318826 |
91 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.86011453 |
92 | JUN_21703547_ChIP-Seq_K562_Human | 0.85867081 |
93 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85535968 |
94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85014240 |
95 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.84551577 |
96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84529364 |
97 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.84148540 |
98 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84143043 |
99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83781063 |
100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83534033 |
101 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83180662 |
102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82115259 |
103 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.80282528 |
104 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.80266563 |
105 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80140769 |
106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80101581 |
107 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.79950669 |
108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79354971 |
109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.78706676 |
110 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.78636119 |
111 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.78531656 |
112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.78390919 |
113 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.77760761 |
114 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.77716986 |
115 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.77638286 |
116 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.77439582 |
117 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.76999205 |
118 | STAT3_23295773_ChIP-Seq_U87_Human | 0.76800547 |
119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.76765882 |
120 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76226668 |
121 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.75980841 |
122 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75552154 |
123 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.74929395 |
124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74741893 |
125 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.74370250 |
126 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.73576774 |
127 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.73306690 |
128 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.73077079 |
129 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.72377075 |
130 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.71392258 |
131 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.71281877 |
132 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.70909737 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.41537104 |
2 | MP0005360_urolithiasis | 3.68140016 |
3 | MP0004859_abnormal_synaptic_plasticity | 3.32797178 |
4 | MP0003880_abnormal_central_pattern | 3.32389570 |
5 | MP0006276_abnormal_autonomic_nervous | 3.17467221 |
6 | MP0005085_abnormal_gallbladder_physiolo | 3.03509285 |
7 | MP0004270_analgesia | 2.85722852 |
8 | MP0003635_abnormal_synaptic_transmissio | 2.80839715 |
9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.73097082 |
10 | MP0005423_abnormal_somatic_nervous | 2.70137129 |
11 | MP0005365_abnormal_bile_salt | 2.67589639 |
12 | MP0002822_catalepsy | 2.51049389 |
13 | MP0001968_abnormal_touch/_nociception | 2.43014833 |
14 | MP0009745_abnormal_behavioral_response | 2.39488075 |
15 | MP0002063_abnormal_learning/memory/cond | 2.32746857 |
16 | MP0002734_abnormal_mechanical_nocicepti | 2.29543042 |
17 | MP0002572_abnormal_emotion/affect_behav | 2.26543307 |
18 | MP0001188_hyperpigmentation | 2.23281397 |
19 | MP0003121_genomic_imprinting | 2.15330413 |
20 | MP0002733_abnormal_thermal_nociception | 2.13726187 |
21 | MP0003787_abnormal_imprinting | 2.13591980 |
22 | MP0003122_maternal_imprinting | 2.12306605 |
23 | MP0002064_seizures | 2.11505570 |
24 | MP0009046_muscle_twitch | 2.06628874 |
25 | MP0005645_abnormal_hypothalamus_physiol | 1.99928811 |
26 | MP0001440_abnormal_grooming_behavior | 1.98100690 |
27 | MP0003123_paternal_imprinting | 1.97184944 |
28 | MP0001486_abnormal_startle_reflex | 1.96506146 |
29 | MP0001501_abnormal_sleep_pattern | 1.96190298 |
30 | MP0001529_abnormal_vocalization | 1.94942530 |
31 | MP0000778_abnormal_nervous_system | 1.88724030 |
32 | MP0002735_abnormal_chemical_nociception | 1.82655792 |
33 | MP0002736_abnormal_nociception_after | 1.80200659 |
34 | MP0002272_abnormal_nervous_system | 1.76645532 |
35 | MP0002184_abnormal_innervation | 1.74834534 |
36 | MP0004133_heterotaxia | 1.69067080 |
37 | MP0003329_amyloid_beta_deposits | 1.67684785 |
38 | MP0002557_abnormal_social/conspecific_i | 1.65439064 |
39 | MP0001970_abnormal_pain_threshold | 1.63412622 |
40 | MP0001905_abnormal_dopamine_level | 1.63205325 |
41 | MP0010329_abnormal_lipoprotein_level | 1.58808493 |
42 | MP0004924_abnormal_behavior | 1.57647493 |
43 | MP0005386_behavior/neurological_phenoty | 1.57647493 |
44 | MP0005083_abnormal_biliary_tract | 1.57152374 |
45 | MP0003252_abnormal_bile_duct | 1.54876296 |
46 | MP0002909_abnormal_adrenal_gland | 1.54736781 |
47 | MP0002067_abnormal_sensory_capabilities | 1.53384249 |
48 | MP0004858_abnormal_nervous_system | 1.52654647 |
49 | MP0003868_abnormal_feces_composition | 1.41930872 |
50 | MP0008872_abnormal_physiological_respon | 1.40561832 |
51 | MP0003011_delayed_dark_adaptation | 1.39311916 |
52 | MP0005499_abnormal_olfactory_system | 1.39133288 |
53 | MP0005394_taste/olfaction_phenotype | 1.39133288 |
54 | MP0004142_abnormal_muscle_tone | 1.38758831 |
55 | MP0000566_synostosis | 1.36909907 |
56 | MP0000955_abnormal_spinal_cord | 1.31060030 |
57 | MP0002653_abnormal_ependyma_morphology | 1.27612103 |
58 | MP0004742_abnormal_vestibular_system | 1.27518121 |
59 | MP0004811_abnormal_neuron_physiology | 1.24865600 |
60 | MP0003890_abnormal_embryonic-extraembry | 1.23895554 |
61 | MP0004147_increased_porphyrin_level | 1.23336330 |
62 | MP0003861_abnormal_nervous_system | 1.16749078 |
63 | MP0002882_abnormal_neuron_morphology | 1.16305347 |
64 | MP0008995_early_reproductive_senescence | 1.15187153 |
65 | MP0005535_abnormal_body_temperature | 1.14005868 |
66 | MP0002066_abnormal_motor_capabilities/c | 1.13459130 |
67 | MP0002638_abnormal_pupillary_reflex | 1.11901231 |
68 | MP0001984_abnormal_olfaction | 1.09679985 |
69 | MP0003283_abnormal_digestive_organ | 1.09324116 |
70 | MP0005332_abnormal_amino_acid | 1.06703692 |
71 | MP0001502_abnormal_circadian_rhythm | 1.05015438 |
72 | MP0006035_abnormal_mitochondrial_morpho | 1.04673299 |
73 | MP0002876_abnormal_thyroid_physiology | 1.03467432 |
74 | MP0000604_amyloidosis | 1.03220829 |
75 | MP0002102_abnormal_ear_morphology | 1.02396164 |
76 | MP0003938_abnormal_ear_development | 1.01081796 |
77 | MP0002751_abnormal_autonomic_nervous | 1.00847839 |
78 | MP0005646_abnormal_pituitary_gland | 1.00813727 |
79 | MP0003119_abnormal_digestive_system | 1.00795172 |
80 | MP0001986_abnormal_taste_sensitivity | 1.00644241 |
81 | MP0002069_abnormal_eating/drinking_beha | 0.99666562 |
82 | MP0001666_abnormal_nutrient_absorption | 0.99630817 |
83 | MP0004019_abnormal_vitamin_homeostasis | 0.98832747 |
84 | MP0005551_abnormal_eye_electrophysiolog | 0.97403633 |
85 | MP0006292_abnormal_olfactory_placode | 0.96689117 |
86 | MP0005379_endocrine/exocrine_gland_phen | 0.95433120 |
87 | MP0002152_abnormal_brain_morphology | 0.92965663 |
88 | MP0000631_abnormal_neuroendocrine_gland | 0.92650603 |
89 | MP0000026_abnormal_inner_ear | 0.90613442 |
90 | MP0003942_abnormal_urinary_system | 0.89917092 |
91 | MP0002118_abnormal_lipid_homeostasis | 0.89308668 |
92 | MP0008789_abnormal_olfactory_epithelium | 0.88616936 |
93 | MP0002837_dystrophic_cardiac_calcinosis | 0.88457345 |
94 | MP0004145_abnormal_muscle_electrophysio | 0.86233602 |
95 | MP0002229_neurodegeneration | 0.86106237 |
96 | MP0003879_abnormal_hair_cell | 0.85735157 |
97 | MP0009780_abnormal_chondrocyte_physiolo | 0.83875720 |
98 | MP0002249_abnormal_larynx_morphology | 0.83844840 |
99 | MP0008961_abnormal_basal_metabolism | 0.82747027 |
100 | MP0002752_abnormal_somatic_nervous | 0.82728203 |
101 | MP0000049_abnormal_middle_ear | 0.82069278 |
102 | MP0008874_decreased_physiological_sensi | 0.78578017 |
103 | MP0005195_abnormal_posterior_eye | 0.78423856 |
104 | MP0008569_lethality_at_weaning | 0.77803379 |
105 | MP0002928_abnormal_bile_duct | 0.77293128 |
106 | MP0005448_abnormal_energy_balance | 0.76789338 |
107 | MP0002081_perinatal_lethality | 0.76785900 |
108 | MP0002163_abnormal_gland_morphology | 0.76538482 |
109 | MP0004885_abnormal_endolymph | 0.76345887 |
110 | MP0001963_abnormal_hearing_physiology | 0.73199201 |
111 | MP0002078_abnormal_glucose_homeostasis | 0.73031485 |
112 | MP0003656_abnormal_erythrocyte_physiolo | 0.72662988 |
113 | MP0000538_abnormal_urinary_bladder | 0.71483522 |
114 | MP0003315_abnormal_perineum_morphology | 0.71205939 |
115 | MP0001348_abnormal_lacrimal_gland | 0.70165794 |
116 | MP0000609_abnormal_liver_physiology | 0.68451455 |
117 | MP0002090_abnormal_vision | 0.67888838 |
118 | MP0006072_abnormal_retinal_apoptosis | 0.67783132 |
119 | MP0010386_abnormal_urinary_bladder | 0.67747713 |
120 | MP0002254_reproductive_system_inflammat | 0.67487869 |
121 | MP0003953_abnormal_hormone_level | 0.67304370 |
122 | MP0009379_abnormal_foot_pigmentation | 0.66908275 |
123 | MP0009840_abnormal_foam_cell | 0.66580416 |
124 | MP0005253_abnormal_eye_physiology | 0.66537453 |
125 | MP0008877_abnormal_DNA_methylation | 0.65680034 |
126 | MP0003195_calcinosis | 0.65078223 |
127 | MP0010770_preweaning_lethality | 0.64641111 |
128 | MP0002082_postnatal_lethality | 0.64641111 |
129 | MP0001943_abnormal_respiration | 0.64358110 |
130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64308313 |
131 | MP0003385_abnormal_body_wall | 0.63443696 |
132 | MP0001299_abnormal_eye_distance/ | 0.62869437 |
133 | MP0002234_abnormal_pharynx_morphology | 0.62698183 |
134 | MP0004130_abnormal_muscle_cell | 0.62426034 |
135 | MP0005187_abnormal_penis_morphology | 0.62059286 |
136 | MP0003631_nervous_system_phenotype | 0.61004249 |
137 | MP0001324_abnormal_eye_pigmentation | 0.60691198 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.40598829 |
2 | Myokymia (HP:0002411) | 4.22559791 |
3 | Limb dystonia (HP:0002451) | 3.91066701 |
4 | Visual hallucinations (HP:0002367) | 3.89192200 |
5 | Focal motor seizures (HP:0011153) | 3.88285851 |
6 | Deep venous thrombosis (HP:0002625) | 3.71660164 |
7 | Hypobetalipoproteinemia (HP:0003563) | 3.68769990 |
8 | Focal seizures (HP:0007359) | 3.67448948 |
9 | Cortical dysplasia (HP:0002539) | 3.64500984 |
10 | Hyperventilation (HP:0002883) | 3.39979601 |
11 | Gait imbalance (HP:0002141) | 3.30372534 |
12 | Abnormality of the lower motor neuron (HP:0002366) | 3.28611776 |
13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.18404816 |
14 | Abnormality of the corticospinal tract (HP:0002492) | 3.17608948 |
15 | Hypochromic microcytic anemia (HP:0004840) | 3.16321692 |
16 | Prolonged partial thromboplastin time (HP:0003645) | 3.08974018 |
17 | Epileptic encephalopathy (HP:0200134) | 3.05913521 |
18 | Intrahepatic cholestasis (HP:0001406) | 3.03088010 |
19 | Febrile seizures (HP:0002373) | 3.02319158 |
20 | Amblyopia (HP:0000646) | 3.00290285 |
21 | Generalized tonic-clonic seizures (HP:0002069) | 2.99423256 |
22 | Xanthomatosis (HP:0000991) | 2.97817745 |
23 | Hypoplasia of the brainstem (HP:0002365) | 2.91113920 |
24 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.91113920 |
25 | Hyperlipoproteinemia (HP:0010980) | 2.89968837 |
26 | Hyperglycinemia (HP:0002154) | 2.88199462 |
27 | Absence seizures (HP:0002121) | 2.83760523 |
28 | Amyotrophic lateral sclerosis (HP:0007354) | 2.83692078 |
29 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.76135155 |
30 | Atonic seizures (HP:0010819) | 2.74925902 |
31 | Dialeptic seizures (HP:0011146) | 2.71901469 |
32 | EEG with generalized epileptiform discharges (HP:0011198) | 2.71460222 |
33 | Failure to thrive in infancy (HP:0001531) | 2.71283981 |
34 | Drooling (HP:0002307) | 2.69834767 |
35 | Excessive salivation (HP:0003781) | 2.69834767 |
36 | Hypsarrhythmia (HP:0002521) | 2.68467270 |
37 | Cerebral inclusion bodies (HP:0100314) | 2.67382074 |
38 | Status epilepticus (HP:0002133) | 2.65117405 |
39 | Supranuclear gaze palsy (HP:0000605) | 2.64092532 |
40 | Epileptiform EEG discharges (HP:0011182) | 2.63685692 |
41 | Abnormality of the labia minora (HP:0012880) | 2.61958009 |
42 | Pachygyria (HP:0001302) | 2.59844161 |
43 | Lissencephaly (HP:0001339) | 2.58809299 |
44 | Agitation (HP:0000713) | 2.56797752 |
45 | Epidermoid cyst (HP:0200040) | 2.56736997 |
46 | Poor suck (HP:0002033) | 2.56036623 |
47 | Polyphagia (HP:0002591) | 2.55710632 |
48 | Retinal dysplasia (HP:0007973) | 2.54320772 |
49 | Congenital primary aphakia (HP:0007707) | 2.50715555 |
50 | Mutism (HP:0002300) | 2.49062674 |
51 | Pheochromocytoma (HP:0002666) | 2.49049083 |
52 | Shawl scrotum (HP:0000049) | 2.48363727 |
53 | Sleep apnea (HP:0010535) | 2.46085849 |
54 | Progressive cerebellar ataxia (HP:0002073) | 2.44682278 |
55 | Impaired social interactions (HP:0000735) | 2.40946559 |
56 | Abnormal social behavior (HP:0012433) | 2.40946559 |
57 | Nephrogenic diabetes insipidus (HP:0009806) | 2.40444443 |
58 | Hepatoblastoma (HP:0002884) | 2.39739501 |
59 | Neurofibrillary tangles (HP:0002185) | 2.38419465 |
60 | Ketosis (HP:0001946) | 2.36319437 |
61 | Medial flaring of the eyebrow (HP:0010747) | 2.34260050 |
62 | Hyperglycinuria (HP:0003108) | 2.32211112 |
63 | Poor eye contact (HP:0000817) | 2.25545973 |
64 | Anxiety (HP:0000739) | 2.24222308 |
65 | Hemiparesis (HP:0001269) | 2.23401604 |
66 | Torticollis (HP:0000473) | 2.21076726 |
67 | Cholecystitis (HP:0001082) | 2.20900434 |
68 | Abnormal gallbladder physiology (HP:0012438) | 2.20900434 |
69 | Neuroendocrine neoplasm (HP:0100634) | 2.20390584 |
70 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19173951 |
71 | Hypolipoproteinemia (HP:0010981) | 2.15328221 |
72 | Poor coordination (HP:0002370) | 2.14233022 |
73 | Complement deficiency (HP:0004431) | 2.13284506 |
74 | Irritability (HP:0000737) | 2.12513553 |
75 | Fetal akinesia sequence (HP:0001989) | 2.12092100 |
76 | Generalized hypotonia (HP:0001290) | 2.09425493 |
77 | Gout (HP:0001997) | 2.09215736 |
78 | Skin nodule (HP:0200036) | 2.08835207 |
79 | Focal dystonia (HP:0004373) | 2.08666070 |
80 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06668181 |
81 | Abnormality of glycine metabolism (HP:0010895) | 2.06668181 |
82 | Restlessness (HP:0000711) | 2.05799359 |
83 | Ketoacidosis (HP:0001993) | 2.04584416 |
84 | Craniofacial dystonia (HP:0012179) | 2.03699308 |
85 | Nephronophthisis (HP:0000090) | 2.03543690 |
86 | Generalized myoclonic seizures (HP:0002123) | 2.03390970 |
87 | Specific learning disability (HP:0001328) | 2.03164666 |
88 | Esotropia (HP:0000565) | 2.02528004 |
89 | Broad-based gait (HP:0002136) | 2.02195252 |
90 | High anterior hairline (HP:0009890) | 2.01913009 |
91 | Urinary urgency (HP:0000012) | 2.01767763 |
92 | Genital tract atresia (HP:0001827) | 1.99233974 |
93 | Polymicrogyria (HP:0002126) | 1.99104481 |
94 | Hyperphosphaturia (HP:0003109) | 1.98391619 |
95 | Vaginal atresia (HP:0000148) | 1.97913599 |
96 | Depression (HP:0000716) | 1.97881900 |
97 | Spastic gait (HP:0002064) | 1.96913557 |
98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95777450 |
99 | Hypoplasia of the corpus callosum (HP:0002079) | 1.95023464 |
100 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.93425678 |
101 | Papilledema (HP:0001085) | 1.93368837 |
102 | Oligodactyly (hands) (HP:0001180) | 1.92324710 |
103 | Neonatal onset (HP:0003623) | 1.92004194 |
104 | Tetraplegia (HP:0002445) | 1.90648883 |
105 | Cerebral edema (HP:0002181) | 1.90542512 |
106 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.90330241 |
107 | Ankle clonus (HP:0011448) | 1.89377313 |
108 | Progressive inability to walk (HP:0002505) | 1.87608434 |
109 | Exotropia (HP:0000577) | 1.87559146 |
110 | Abnormal eating behavior (HP:0100738) | 1.86900631 |
111 | Acute encephalopathy (HP:0006846) | 1.86245684 |
112 | Inability to walk (HP:0002540) | 1.85291844 |
113 | Absent speech (HP:0001344) | 1.84929967 |
114 | Renal cortical cysts (HP:0000803) | 1.84479501 |
115 | Protruding tongue (HP:0010808) | 1.84243111 |
116 | Delusions (HP:0000746) | 1.83685231 |
117 | Hyperammonemia (HP:0001987) | 1.83062459 |
118 | Muscular hypotonia of the trunk (HP:0008936) | 1.83018833 |
119 | Reticulocytosis (HP:0001923) | 1.81430362 |
120 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.80957279 |
121 | Akinesia (HP:0002304) | 1.80942790 |
122 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.80726878 |
123 | Molar tooth sign on MRI (HP:0002419) | 1.80681901 |
124 | Abnormality of midbrain morphology (HP:0002418) | 1.80681901 |
125 | Abnormal hair whorl (HP:0010721) | 1.80043926 |
126 | Tubulointerstitial nephritis (HP:0001970) | 1.78900421 |
127 | Hyperbilirubinemia (HP:0002904) | 1.77901954 |
128 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.77852014 |
129 | Abnormal pupillary function (HP:0007686) | 1.77835668 |
130 | Hypothermia (HP:0002045) | 1.77443594 |
131 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.77354999 |
132 | Spastic tetraplegia (HP:0002510) | 1.75346725 |
133 | Hyperthyroidism (HP:0000836) | 1.75201199 |
134 | Delayed myelination (HP:0012448) | 1.74322453 |
135 | Intellectual disability, severe (HP:0010864) | 1.72846901 |
136 | Abnormality of the renal medulla (HP:0100957) | 1.71591456 |
137 | Narrow forehead (HP:0000341) | 1.63244755 |
138 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.62861210 |
139 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.62861210 |
140 | Patellar aplasia (HP:0006443) | 1.62858662 |
141 | Genetic anticipation (HP:0003743) | 1.60052713 |
142 | Long foot (HP:0001833) | 1.58926970 |
143 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.57413379 |
144 | Labial hypoplasia (HP:0000066) | 1.56126291 |
145 | Action tremor (HP:0002345) | 1.55528014 |
146 | Optic nerve coloboma (HP:0000588) | 1.54143426 |
147 | Thyroid-stimulating hormone excess (HP:0002925) | 1.53594597 |
148 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.51687873 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MARK1 | 5.31671377 |
2 | MAP3K9 | 3.61898000 |
3 | NTRK3 | 3.27794892 |
4 | TAOK3 | 3.03768523 |
5 | GRK5 | 2.94070018 |
6 | CASK | 2.77824244 |
7 | NTRK2 | 2.72385085 |
8 | PNCK | 2.65831002 |
9 | MAP3K4 | 2.60412578 |
10 | MAP2K4 | 2.37212466 |
11 | NTRK1 | 2.30234530 |
12 | MINK1 | 2.24502730 |
13 | MAP2K7 | 2.19510103 |
14 | MAPK13 | 2.04435276 |
15 | GRK6 | 1.98487122 |
16 | DYRK2 | 1.94774533 |
17 | DAPK2 | 1.86456350 |
18 | SIK2 | 1.80299918 |
19 | UHMK1 | 1.74592763 |
20 | EPHA4 | 1.73813571 |
21 | MAP4K2 | 1.64482498 |
22 | MAP3K6 | 1.57487030 |
23 | MAP3K12 | 1.56138472 |
24 | PAK6 | 1.48510293 |
25 | LATS2 | 1.46875246 |
26 | PHKG1 | 1.43839717 |
27 | PHKG2 | 1.43839717 |
28 | TNIK | 1.30266442 |
29 | DYRK3 | 1.29562699 |
30 | DYRK1B | 1.29006772 |
31 | TRIM28 | 1.27437171 |
32 | CSNK1G2 | 1.24285918 |
33 | ARAF | 1.22503264 |
34 | CDK5 | 1.22057812 |
35 | GRK7 | 1.17764171 |
36 | EPHB2 | 1.17509332 |
37 | KSR2 | 1.16432040 |
38 | PRKCG | 1.14516310 |
39 | KSR1 | 1.12851055 |
40 | WNK3 | 1.09860270 |
41 | CSNK1G3 | 1.05144283 |
42 | TLK1 | 1.02957878 |
43 | WNK4 | 1.00900939 |
44 | ADRBK2 | 0.99867970 |
45 | DYRK1A | 0.98529083 |
46 | MARK2 | 0.96562426 |
47 | PAK3 | 0.95582453 |
48 | CAMK2A | 0.94364445 |
49 | TAOK1 | 0.93365343 |
50 | EPHA3 | 0.89801922 |
51 | DAPK1 | 0.88146511 |
52 | PKN1 | 0.86866600 |
53 | ADRBK1 | 0.85061167 |
54 | PINK1 | 0.84514047 |
55 | PRKCZ | 0.82166477 |
56 | CDK14 | 0.78264402 |
57 | CDK15 | 0.78135670 |
58 | CDK18 | 0.77492466 |
59 | STK11 | 0.74369605 |
60 | MAPK12 | 0.73777531 |
61 | NME1 | 0.73750414 |
62 | AKT3 | 0.72435049 |
63 | PLK2 | 0.70478217 |
64 | SIK1 | 0.69944714 |
65 | CDK11A | 0.69356607 |
66 | MAP2K6 | 0.68233981 |
67 | TYRO3 | 0.67823355 |
68 | PRKD3 | 0.66885761 |
69 | SGK2 | 0.64933689 |
70 | CAMK2B | 0.64018002 |
71 | CSNK1G1 | 0.62447807 |
72 | MAPK4 | 0.62015584 |
73 | GRK1 | 0.60158487 |
74 | MAPK15 | 0.59402734 |
75 | SRPK1 | 0.59380653 |
76 | CAMKK1 | 0.58713013 |
77 | RET | 0.58150674 |
78 | INSRR | 0.57392992 |
79 | NEK2 | 0.56645130 |
80 | MAP3K2 | 0.53710754 |
81 | SGK1 | 0.53370996 |
82 | CAMK1G | 0.52122726 |
83 | ERBB4 | 0.51911913 |
84 | CAMK2G | 0.51425829 |
85 | CDK19 | 0.51317865 |
86 | LMTK2 | 0.50356723 |
87 | CAMK4 | 0.49511305 |
88 | RPS6KA2 | 0.47645728 |
89 | CSNK1E | 0.46361877 |
90 | PRKCE | 0.44811056 |
91 | PRKACG | 0.44787351 |
92 | MATK | 0.44585743 |
93 | RIPK4 | 0.44153344 |
94 | RPS6KA4 | 0.43792142 |
95 | CSNK1A1 | 0.43516459 |
96 | ERBB2 | 0.42796509 |
97 | ICK | 0.42569246 |
98 | GSK3B | 0.42391796 |
99 | ABL2 | 0.40790380 |
100 | MAPK8 | 0.40777579 |
101 | CSNK1D | 0.40603517 |
102 | PRKACA | 0.39895675 |
103 | PRKAA1 | 0.39677971 |
104 | RPS6KA3 | 0.39673046 |
105 | FGFR2 | 0.39177059 |
106 | CDC7 | 0.38582518 |
107 | ERBB3 | 0.36671502 |
108 | STK38 | 0.36092828 |
109 | BCR | 0.35972411 |
110 | FES | 0.35596030 |
111 | CDK1 | 0.35197259 |
112 | CAMK1 | 0.35176866 |
113 | CSNK1A1L | 0.34745195 |
114 | PRKDC | 0.34715680 |
115 | MAP2K1 | 0.33968456 |
116 | MAPKAPK5 | 0.33222941 |
117 | GSK3A | 0.33112449 |
118 | PRKACB | 0.32605086 |
119 | PRKG1 | 0.32186645 |
120 | SGK494 | 0.32157697 |
121 | SGK223 | 0.32157697 |
122 | PRKCI | 0.32143853 |
123 | MAPK9 | 0.32096485 |
124 | MAP3K10 | 0.31928575 |
125 | PKN2 | 0.31785462 |
126 | CDK2 | 0.31228045 |
127 | MAPK14 | 0.30837608 |
128 | PTK2 | 0.30359080 |
129 | SIK3 | 0.30274469 |
130 | RPS6KB1 | 0.30107096 |
131 | BMPR1B | 0.29909177 |
132 | SGK3 | 0.27701958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.90928860 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.85975990 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.58101158 |
4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.43204561 |
5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32602622 |
6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.22185541 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16796061 |
8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.14750897 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09399961 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07287205 |
11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.94752353 |
12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89945218 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.70017230 |
14 | Bile secretion_Homo sapiens_hsa04976 | 1.67301814 |
15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56142008 |
16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53597503 |
17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.53502995 |
18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46832995 |
19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.45386366 |
20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44934995 |
21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.39860334 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36956899 |
23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.36404821 |
24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36001784 |
25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35605799 |
26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.34869455 |
27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.34546724 |
28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.34361653 |
29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32518063 |
30 | Taste transduction_Homo sapiens_hsa04742 | 1.30953416 |
31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29317704 |
32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28666582 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28320111 |
34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.27770150 |
35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25085005 |
36 | Insulin secretion_Homo sapiens_hsa04911 | 1.24726687 |
37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24390936 |
38 | Morphine addiction_Homo sapiens_hsa05032 | 1.24330689 |
39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.24101960 |
40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23721701 |
41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.20300396 |
42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16747528 |
43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11622138 |
44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.09232009 |
45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.08152537 |
46 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06769132 |
47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06148872 |
48 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.05160522 |
49 | Long-term potentiation_Homo sapiens_hsa04720 | 1.03763030 |
50 | Olfactory transduction_Homo sapiens_hsa04740 | 1.03502452 |
51 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02090154 |
52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00308040 |
53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99228179 |
54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97158137 |
55 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96254762 |
56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.94197022 |
57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93230612 |
58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.91292073 |
59 | Salivary secretion_Homo sapiens_hsa04970 | 0.91168836 |
60 | Peroxisome_Homo sapiens_hsa04146 | 0.90642107 |
61 | Long-term depression_Homo sapiens_hsa04730 | 0.90320125 |
62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87338516 |
63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86949604 |
64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.85447137 |
65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83653025 |
66 | Axon guidance_Homo sapiens_hsa04360 | 0.79855518 |
67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79783172 |
68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.78784819 |
69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77918877 |
70 | Gap junction_Homo sapiens_hsa04540 | 0.77809783 |
71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77732815 |
72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77625048 |
73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74416389 |
74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73281321 |
75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72295322 |
76 | Renin secretion_Homo sapiens_hsa04924 | 0.72185041 |
77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71500674 |
78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71046463 |
79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70194039 |
80 | Alcoholism_Homo sapiens_hsa05034 | 0.68478014 |
81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67927719 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.67606724 |
83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66405062 |
84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65904412 |
85 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.65595097 |
86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63933900 |
87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63901589 |
88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61261402 |
89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60858893 |
90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59793047 |
91 | ABC transporters_Homo sapiens_hsa02010 | 0.59143417 |
92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57693368 |
93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57030391 |
94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56466025 |
95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55781183 |
96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55639943 |
97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55089312 |
98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54449326 |
99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53174426 |
100 | Protein export_Homo sapiens_hsa03060 | 0.52996471 |
101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51601227 |
102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51442970 |
103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50945517 |
104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50644857 |
105 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48566721 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48098646 |
107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47333586 |
108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47212991 |
109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46600324 |
110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44780623 |
111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44567071 |
112 | Phototransduction_Homo sapiens_hsa04744 | 0.43734334 |
113 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43007062 |
114 | Melanogenesis_Homo sapiens_hsa04916 | 0.42560596 |
115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42217974 |
116 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41104096 |
117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40654972 |
118 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40514617 |
119 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39444067 |
120 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39232790 |
121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39210522 |
122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38929535 |
123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37521486 |
124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37502256 |
125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36759331 |